🇺🇸 FDA
Patent

US 8673629

Recombinant Rift Valley fever (RVF) viruses and methods of use

granted A61KA61K2039/525A61K2039/5254

Quick answer

US patent 8673629 (Recombinant Rift Valley fever (RVF) viruses and methods of use) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/525, A61K2039/5254, A61K35/76, A61K39/00